EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
Liver Cirrhosis
Hemostasis
03 medical and health sciences
0302 clinical medicine
Anticoagulants
Humans
Hemorrhage
Thrombosis
Venous Thromboembolism
3. Good health
DOI:
10.1016/j.jhep.2021.09.003
Publication Date:
2022-03-15T02:01:07Z
AUTHORS (10)
ABSTRACT
The prevention and management of bleeding and thrombosis in patients with cirrhosis poses several difficult clinical questions. These Clinical Practice Guidelines have been developed to provide practical guidance on debated topics, including current views on haemostasis in liver disease, controversy regarding the need to correct thrombocytopenia and abnormalities in the coagulation system in patients undergoing invasive procedures, and the need for thromboprophylaxis in hospitalised patients with haemostatic abnormalities. Multiple recommendations in this document are based on interventions that the panel feels are not useful, even though widely applied in clinical practice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (339)
CITATIONS (201)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....